Protara Therapeutics Eulerpool News

Protara Therapeutics Stock News

Protara Therapeutics is being monitored by journalists and investors worldwide. We gather the latest Protara Therapeutics news here.

• November 15 ·

  Yahoo
  Protara Therapeutics to Present New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the 25th Annual Meeting of the Society of Urologic Oncology
• November 12 ·

  Yahoo
  Protara Therapeutics Announces Third Quarter 2024 Financial Results and Provides a Business Update
• November 6 ·

  Yahoo
  Protara Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference
• October 21 ·

  Yahoo
  Protara Therapeutics Granted FDA Fast Track Designation for Intravenous Choline Chloride for Patients Receiving Parenteral Support
• September 13 ·

  GuruFocus
  Opaleye Management Inc. Reduces Stake in Protara Therapeutics Inc.
• September 9 ·

  Yahoo
  Protara Therapeutics Announces Completion of First Cohort in Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations
• September 9 ·

  Yahoo
  Protara Therapeutics Announces Results from THRIVE-1, a Prospective Observational Study Evaluating the Prevalence of Choline Deficiency and Liver Injury in Patients Dependent on Parenteral Support
• September 3 ·

  Yahoo
  Protara Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
• August 28 ·

  Associated Press, The
  Veeva: Fiscal Q2 Earnings Snapshot
• August 12 ·

  Thefly.com
  Protara Therapeutics price target lowered by $5 at Oppenheimer, here's why